Get the Stockscreener App
3.07
1.29%
-0.04
Puma Biotechnology Inc stock is traded at $3.07, with a volume of 230.77K.
It is down -1.29% in the last 24 hours and down -14.48% over the past month.
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
See More
Previous Close:
$3.11
Open:
$3.1
24h Volume:
230.77K
Relative Volume:
0.65
Market Cap:
$152.37M
Revenue:
$230.47M
Net Income/Loss:
$30.28M
P/E Ratio:
5.0328
EPS:
0.61
Net Cash Flow:
$38.86M
1W Performance:
-6.40%
1M Performance:
-14.48%
6M Performance:
+6.23%
1Y Performance:
-12.29%
1-Day Range:
$3.03
$3.10
1-Week Range:
$3.03
$3.41
52-Week Range:
$2.225
$4.13
Puma Biotechnology Inc Stock (PBYI) Company Profile
Name
Puma Biotechnology Inc
Sector
Industry
Phone
(424) 248-6500
Address
10880 WILSHIRE BLVD., LOS ANGELES, CA
Compare PBYI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
3.07 | 154.37M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Underperform |
| Oct-08-19 | Downgrade | Goldman | Neutral → Sell |
| May-10-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-10-19 | Downgrade | Citigroup | Buy → Neutral |
| Jan-17-19 | Initiated | Leerink Partners | Mkt Perform |
| Jan-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-19-18 | Upgrade | Goldman | Sell → Neutral |
| Nov-02-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Nov-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-17-18 | Initiated | Goldman | Sell |
| May-11-18 | Reiterated | Stifel | Buy |
| Nov-10-17 | Reiterated | Citigroup | Buy |
| Nov-10-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-02-17 | Reiterated | Stifel | Buy |
| Sep-11-17 | Reiterated | Credit Suisse | Outperform |
| Jul-10-17 | Resumed | Leerink Partners | Outperform |
| Jun-06-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-25-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Mar-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Puma Biotechnology Inc Stock (PBYI) Latest News
Volatility clustering patterns for Puma Biotechnology Inc.Daily Breakout List with Smart Filters - Newser
What makes Puma Biotechnology Inc. stock price move sharplyEarnings Report Insights With High Returns - jammulinksnews.com
How sentiment analysis helps forecast Puma Biotechnology Inc.Free Fast Entry High Potential Stock Alerts - Newser
How to monitor Puma Biotechnology Inc. with trend dashboardsShort-Term Stock Trend Forecast Guide - Newser
How to use a screener to detect Puma Biotechnology Inc. breakoutsAI Stock Movement Forecast with Accuracy - Newser
Does Puma Biotechnology Inc. stock pay reliable dividendsBeginner Friendly Stock Selection Guide Updated - metal.it
Why Puma Biotechnology Inc. stock attracts strong analyst attentionEarly Entry Tips With Low Risk Zone Shared - metal.it
Predicting Puma Biotechnology Inc. trend using moving averagesWeekly Trend Watch with Market Signals - Newser
Can volume confirm reversal in Puma Biotechnology Inc.Daily Market Momentum Summary and Strategy - Newser
Signal strength of Puma Biotechnology Inc. stock in tech scannersFree Safe Entry Stock Watch Suggestions - Newser
Puma Biotechnology Inc. stock trend forecastTop Stock Picks with Forecast Accuracy - Newser
Trend Reversal Possible in Puma Biotechnology Inc. Charts IndicateMarket Entry and Exit Point Tips From Traders - metal.it
Quant Funds Rotate Into Puma Biotechnology Inc. StockConsistent Income Focused Trade List Analyzed - metal.it
What catalysts could drive Puma Biotechnology Inc. stock higher in 2025Exceptional earning trajectories - jammulinksnews.com
Is Puma Biotechnology Inc. trending in predictive chart models Free Market Entry and Exit Point Tips - Newser
What are the technical indicators suggesting about Puma Biotechnology Inc.Grow your portfolio with growth-oriented stocks - jammulinksnews.com
What are analysts’ price targets for Puma Biotechnology Inc. in the next 12 monthsTremendous return rates - jammulinksnews.com
Is it the right time to buy Puma Biotechnology Inc. stockDiscover high-impact stocks for growth - jammulinksnews.com
How strong is Puma Biotechnology Inc. company’s balance sheetMaximize your portfolio’s earning potential - jammulinksnews.com
Is Puma Biotechnology Inc. a growth stock or a value stockBreakthrough profits - jammulinksnews.com
What are the latest earnings results for Puma Biotechnology Inc.Get timely alerts on top market movers - jammulinksnews.com
What are Puma Biotechnology Inc. company’s key revenue driversBuild wealth steadily with proven methods - jammulinksnews.com
why puma biotechnology inc. stock attracts strong analyst attentionSteady Income Ideas - Newser
Will Puma Biotechnology Inc. stock benefit from interest rate changesDynamic investment growth - jammulinksnews.com
Is Puma Biotechnology Inc. a good long term investmentOverwhelming financial success - PrintWeekIndia
What analysts say about Puma Biotechnology Inc. stockRapid wealth creation - PrintWeekIndia
What drives Puma Biotechnology Inc. stock priceOverwhelming financial success - Autocar Professional
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results - BioSpace
Puma Biotechnology Inc. Stock Analysis and ForecastTriple-digit profit margins - jammulinksnews.com
Puma Biotechnology Inc Stock (PBYI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):